Nucleic Acid Therapeutics is a leading peer-reviewed journal published by Mary Ann Liebert, Inc that focuses on the forefront of research in the fields of biochemistry, drug discovery, genetics, and molecular medicine. With an impressive Q1 ranking across multiple categories, including biochemistry and drug discovery, the journal aims to disseminate innovative findings on nucleic acid-based therapies, their mechanisms, and clinical applications. The journal is dedicated to advancing the understanding of nucleic acids in the development of new therapeutic strategies, appealing to a diverse audience of researchers, professionals, and students alike. Given its commitment to open access publishing, Nucleic Acid Therapeutics ensures that groundbreaking research is accessible, fostering collaboration and dialogue in this critical area of scientific inquiry. Situated in the United States, Nucleic Acid Therapeutics plays a pivotal role in connecting researchers and practitioners in the ever-evolving landscape of molecular medicine and biotechnology.

Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.

GENOMICS is a prestigious journal published by Academic Press Inc Elsevier Science, dedicated to advancing the field of genetic research and molecular biology. With an impressive impact factor, this journal is recognized for its rigorous peer-review process and high-quality publications that cover a wide range of topics within the genomics discipline. Operating from the United States, GENOMICS has established itself as a vital resource for researchers, professionals, and students alike, standing at Q2 in the Genetics category according to the latest rankings. With a rich history dating back to 1987 and convergence extending to 2024, the journal highlights cutting-edge discoveries and methodologies, ensuring that its readership remains at the forefront of genetic advancements. Although currently not an open-access journal, articles published within its pages are often accessible through various academic platforms, enhancing worldwide reach and dissemination. For those engaged in the fields of biochemistry, genetics, and molecular biology, GENOMICS serves as an indispensable platform for impactful research and collaborative initiatives.

CURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.

Nucleus is a distinguished academic journal published by Taylor & Francis Inc, dedicated to advancing the fields of Cell Biology and Medicine. Since its inception, the journal has gained significant recognition, achieving a Q1 ranking in both Cell Biology and Medicine (miscellaneous) categories in 2023. With a focus on innovative research that intersects molecular biology and genetics, Nucleus serves as a vital platform for researchers and professionals aiming to disseminate findings that contribute to our understanding of cellular mechanisms and their implications in health and disease. The journal's commitment to Open Access since 2018 ensures that cutting-edge research is readily available to the global community, fostering collaboration and engagement across disciplines. Located in Philadelphia, PA, Nucleus not only aims to publish high-quality articles but also aspires to influence future research directions in the biological sciences, making it an essential resource for anyone involved in the life sciences.

Biochimica et Biophysica Acta-Gene Regulatory Mechanisms, published by Elsevier, stands as a premier academic journal within the realms of biochemistry, biophysics, genetics, and molecular biology. With an impressive Q1 category ranking across several disciplines and a commendable Scopus percentile ranking of 89th in its field, the journal is a significant contributor to the scientific community, promoting groundbreaking research and discoveries from 2008 to 2024. Although it does not currently operate under an open access model, researchers accessing this journal will find in-depth articles that advance understanding of gene regulatory mechanisms and their implications for health and disease. The journal's location in the Netherlands enriches its global perspective, attracting a diverse range of submissions that reflect the cutting edge of science today. By publishing high-quality, peer-reviewed research, Biochimica et Biophysica Acta-Gene Regulatory Mechanisms continues to foster knowledge and innovation, making it an essential resource for researchers, professionals, and students alike seeking to delve deeper into the molecular underpinnings of life.

GENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, published by BEGELL HOUSE INC, serves as a vital resource within the fields of Genetics and Molecular Biology. With the ISSN 1045-4403 and E-ISSN 2162-6502, this journal has been contributing to scientific discourse since 1990 and is projected to continue its publication until 2024. Despite its classification in the Q3 quartile for both Genetics and Molecular Biology, its impact on the research community is significant, as evidenced by its diverse range of critical reviews that synthesize and analyze emerging trends and foundational studies in gene expression. The journal, located in the United States at 50 North St, Danbury, CT 06810, offers a platform for researchers, professionals, and students to engage with innovative ideas and methodologies that drive forward the understanding of gene regulatory mechanisms in eukaryotes. Although it currently does not offer open access, the journal's content remains crucial for those dedicated to advancing knowledge in the intricacies of genetic expression.